E.E.S. Drug Patent Profile

« Back to Dashboard

Which patents cover E.e.s., and when can generic versions of E.e.s. launch?

E.e.s. is a drug marketed by Carnegie, Azurity, Arbor Pharms Llc, and Pharmobedient. and is included in four NDAs.

The generic ingredient in E.E.S. is erythromycin ethylsuccinate. There is one drug master file entry for this compound. Ten suppliers are listed for this compound. Additional details are available on the erythromycin ethylsuccinate profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for E.e.s.

A generic version of E.E.S. was approved as erythromycin ethylsuccinate by CARNEGIE on December 31^st, 1969.

Summary for E.E.S.

US Patents:	0
Applicants:	4
NDAs:	4
Finished Product Suppliers / Packagers:	3
Raw Ingredient (Bulk) Api Vendors:	68
Patent Applications:	1,474
Drug Prices:	Drug price information for E.E.S.
DailyMed Link:	E.E.S. at DailyMed

See drug prices for E.E.S.

Pharmacology for E.E.S.

Drug Class	Macrolide Antimicrobial Macrolide
Physiological Effect	Decreased Sebaceous Gland Activity

US Patents and Regulatory Information for E.E.S.

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Carnegie	E.E.S.	erythromycin ethylsuccinate	GRANULE;ORAL	050207-001	Approved Prior to Jan 1, 1982	AB	RX	Yes	No
Arbor Pharms Llc	E.E.S. 400	erythromycin ethylsuccinate	SUSPENSION;ORAL	061639-002	Approved Prior to Jan 1, 1982		DISCN	No	No
Azurity	E.E.S.	erythromycin ethylsuccinate	TABLET, CHEWABLE;ORAL	050297-002	Approved Prior to Jan 1, 1982		DISCN	No	No
Arbor Pharms Llc	E.E.S. 200	erythromycin ethylsuccinate	SUSPENSION;ORAL	061639-001	Approved Prior to Jan 1, 1982		DISCN	No	No
Pharmobedient	E.E.S. 400	erythromycin ethylsuccinate	TABLET;ORAL	061905-002	Aug 12, 1982	BX	RX	No	Yes
Pharmobedient	E.E.S. 400	erythromycin ethylsuccinate	TABLET;ORAL	061905-001	Approved Prior to Jan 1, 1982		DISCN	No	No